Blood

What Blood does

Blood is a privately held, for-profit company founded in 2018 with a registered web presence at blood.com. The company's public-facing website currently displays only a "Coming soon!" placeholder, and there are no disclosed products, services, pricing models, headcount figures, leadership appointments, funding rounds, partnerships, customer relationships, or geographic operations in the available source material. No firmographic detail beyond the legal name, founding year, private IPO status, for-profit structure, and website URL is present.

The only technology-adjacent information associated with the company in the input is drawn from a general educational article about medical diagnostics that discusses AI-assisted imaging interpretation, predictive modeling, clinical decision support, liquid biopsies, and genomic analysis as broad trends in the diagnostics field. The source commentary explicitly notes this is not a company profile for Blood, and there is no indication that any of these capabilities are being developed, offered, or productized by the company itself.

Because there is no disclosed business model, revenue mechanics, customer segment, or go-to-market motion, the company's commercial stage cannot be characterized with confidence. The most parsimonious reading of the evidence is that Blood is either a stealth-stage entity that has not yet published any operational or commercial disclosure, or a placeholder/holding web presence; the available data does not support either interpretation over the other.

Name

Blood

Website

https://blood.com

Company type

Private

Founded year

2018

Short description

Blood is a privately held for-profit company founded in 2018 whose public website at blood.com currently displays a "Coming soon!" placeholder, with no disclosed products, services, leadership, customers, funding, or operational activity in the available source data.

Ownership category

akta.pro rank

Product category

Medical Diagnostics

NAICS

Medical Laboratories (621511)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAHAAAB

Hematology & Coagulation Diagnostics

Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

• Medical diagnostics
• Blood testing services
• Clinical laboratory testing
• Health data analytics
• Diagnostic decision support

GTM type

B2B

Offering type

Services

Core offering

Blood (blood.com) is registered as a private, for-profit company founded in 2018 whose public-facing website currently displays only "Coming soon!" No specific products, services, or operating business activities are disclosed by the company in the available source data. The article content associated with the blood.com domain is a general educational overview of medical diagnostics, not a product or service offering from the company itself.

Product overview

No specific company products or services are described in the source data. The article provides a general educational overview of medical diagnostics including laboratory testing (blood tests, biomarkers, cultures, genetic assays), imaging modalities (X-ray, ultrasound, CT scan, MRI, DEXA, PET scans), and tissue sampling procedures used in clinical diagnostics. Liquid biopsies for cancer detection are mentioned as an emerging non-invasive diagnostic approach.

Differentiator

Problem solved

Functional benefit

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Direct peers

• GRAIL: GRAIL is a clinical-stage company developing blood-based tests for early cancer detection using methylation and next-generation sequencing — directly comparable as a multi-cancer early-detection blood diagnostics peer.
• Natera: Natera develops and commercializes blood-based (cell-free DNA) genetic testing across oncology, reproductive health, and organ transplantation — a direct peer for any company pursuing molecular blood diagnostics.
• Guardant Health: Guardant Health is a leading blood-based cancer diagnostics company focused on liquid biopsy and genomic profiling from blood samples — directly comparable to an AI/blood-diagnostics company that would compete in oncology liquid biopsy and minimal residual disease monitoring.
• Tempus AI: Tempus applies AI and machine learning to clinical and molecular data including blood-based profiling, and pairs data analytics with diagnostics — directly comparable to an AI-enabled blood diagnostics entrant.

Emerging players

• Personalis: Personalis provides genomic profiling from blood and tissue samples with an emphasis on immuno-oncology and minimal residual disease — an emerging peer that overlaps with a blood-based, AI-augmented diagnostics thesis.

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is one of the largest clinical laboratory networks in the U.S., offering a broad menu of blood-based diagnostic tests — comparable as a broad incumbent that any blood-diagnostics entrant must position against for physician adoption and payor contracts.
• Exact Sciences: Exact Sciences is a diagnostics company with Cologuard and an expanding oncology blood-testing pipeline (e.g., Oncotype, Prevail) — a broad incumbent comparable as an established diagnostics franchise extending into blood-based cancer detection.
• Foundation Medicine: Foundation Medicine (a Roche subsidiary) offers tissue and blood-based comprehensive genomic profiling for cancer; it is a broad incumbent in molecular diagnostics and a likely competitor or partner for any blood-diagnostics company targeting oncology.
• NeoGenomics: NeoGenomics operates a specialty oncology-focused clinical laboratory serving hospitals and oncologists with hematology and molecular testing — comparable as a blood/hematology diagnostics franchise overlapping with the subject's likely category.
• Laboratory Corporation of America (Labcorp): Labcorp is a global clinical laboratory operator with extensive blood-based testing capabilities, including specialty and esoteric diagnostics — directly comparable to a blood diagnostics company competing for hospital and physician send-out volume.

Market position

Strengths3 records

Weaknesses4 records

Key risks5 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blood